Goldman Sachs Group Inc Allogene Therapeutics, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,162,603 shares of ALLO stock, worth $4.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,162,603
Previous 1,530,047 41.34%
Holding current value
$4.91 Million
Previous $3.57 Million 69.85%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.08 - $3.5 $1.32 Million - $2.21 Million
632,556 Added 41.34%
2,162,603 $6.06 Million
Q2 2024

Aug 13, 2024
BUY
$2.23 - $4.38 $524,944 - $1.03 Million
235,401 Added 18.18%
1,530,047 $3.57 Million
Q1 2024

May 15, 2024
SELL
$2.92 - $5.63 $5.96 Million - $11.5 Million
-2,042,568 Reduced 61.21%
1,294,646 $5.79 Million
Q4 2023

Feb 13, 2024
BUY
$2.28 - $3.5 $4.4 Million - $6.75 Million
1,929,258 Added 137.03%
3,337,214 $10.7 Million
Q3 2023

May 14, 2024
SELL
$3.17 - $5.96 $6.12 Million - $11.5 Million
-1,929,258 Reduced 57.81%
1,407,956 $4.46 Million
Q3 2023

Nov 14, 2023
SELL
$3.17 - $5.96 $291,690 - $548,415
-92,016 Reduced 6.13%
1,407,956 $4.46 Million
Q2 2023

May 14, 2024
BUY
$4.53 - $6.74 $1.56 Million - $2.33 Million
345,447 Added 29.92%
1,499,972 $7.45 Million
Q2 2023

Aug 14, 2023
BUY
$4.53 - $6.74 $1.56 Million - $2.33 Million
345,447 Added 29.92%
1,499,972 $7.45 Million
Q1 2023

May 14, 2024
SELL
$4.92 - $8.21 $2.28 Million - $3.81 Million
-463,600 Reduced 28.65%
1,154,525 $5.7 Million
Q1 2023

May 11, 2023
SELL
$4.92 - $8.21 $2.28 Million - $3.81 Million
-463,600 Reduced 28.65%
1,154,525 $5.7 Million
Q4 2022

May 14, 2024
SELL
$5.62 - $11.11 $4.39 Million - $8.68 Million
-781,458 Reduced 32.57%
1,618,125 $10.2 Million
Q4 2022

Feb 13, 2023
SELL
$5.62 - $11.11 $4.39 Million - $8.68 Million
-781,458 Reduced 32.57%
1,618,125 $10.2 Million
Q3 2022

May 14, 2024
BUY
$10.32 - $17.28 $4.38 Million - $7.34 Million
424,626 Added 21.5%
2,399,583 $25.9 Million
Q3 2022

Nov 10, 2022
BUY
$10.32 - $17.28 $4.38 Million - $7.34 Million
424,626 Added 21.5%
2,399,583 $25.9 Million
Q2 2022

May 14, 2024
SELL
$6.78 - $12.28 $9.24 Million - $16.7 Million
-1,362,257 Reduced 40.82%
1,974,957 $22.5 Million
Q2 2022

Aug 15, 2022
SELL
$6.78 - $12.28 $6.69 Million - $12.1 Million
-987,252 Reduced 33.33%
1,974,957 $22.5 Million
Q1 2022

May 16, 2022
BUY
$7.65 - $15.29 $8.71 Million - $17.4 Million
1,138,944 Added 62.47%
2,962,209 $27 Million
Q4 2021

Feb 14, 2022
SELL
$13.13 - $24.52 $2.05 Million - $3.84 Million
-156,447 Reduced 7.9%
1,823,265 $27.2 Million
Q3 2021

Nov 10, 2021
BUY
$21.01 - $27.64 $41.6 Million - $54.7 Million
1,979,712 New
1,979,712 $50.9 Million

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email